We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| GSK plc | NYSE:GSK | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 43.35 | 0 | 01:00:00 |
From May 2019 to May 2024
LONDON-- GlaxoSmithKline PLC (GSK.LN) Wednesday said a Phase III study of its shingles vaccine Shingrix showed a strong immune response in older adults, meeting its primary objective.
Shares at 1309GMT, down 13 pence, or 0.8%, at 1,680 pence valuing the company at GBP82.62 billion
-Write to Rory Gallivan at rory.gallivan@wsj.com; Twitter: @RoryGallivan
(END) Dow Jones Newswires
June 21, 2017 09:25 ET (13:25 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
